Blinding and bias in randomized controlled trials: when to measure the effectiveness of blinding

被引:1
作者
Copeland, Lisa [1 ]
Edwards, Priya [1 ]
Sakzewski, Leanne [2 ]
Thorley, Megan [1 ]
Kentish, Megan [1 ]
Ware, Robert S. [3 ]
Boyd, Roslyn N. [2 ]
机构
[1] Queensland Childrens Hosp, Queensland Paediat Rehabil Serv, South Brisbane, Qld, Australia
[2] Univ Queensland, Queensland Cerebral Palsy & Rehabil Res Ctr, Brisbane, Qld, Australia
[3] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia
关键词
BOTULINUM-TOXIN-A;
D O I
10.1111/dmcn.14369
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This article is commented on by Day on page 159 of this issue.
引用
收藏
页码:260 / 260
页数:1
相关论文
共 4 条
  • [1] Botulinum Toxin A for Nonambulatory Children with Cerebral Palsy: A Double Blind Randomized Controlled Trial
    Copeland, Lisa
    Edwards, Priya
    Thorley, Megan
    Donaghey, Samantha
    Gascoigne-Pees, Laura
    Kentish, Megan
    Lindsley, Jayne
    McLennan, Kim
    Sakzewski, Leanne
    Boyd, Roslyn N.
    [J]. JOURNAL OF PEDIATRICS, 2014, 165 (01) : 140 - +
  • [2] Corry IS, 1997, DEV MED CHILD NEUROL, V39, P185
  • [3] Botulinum neurotoxin A, blinding, and bias
    Hastings-Ison, Tandy
    Graham, Kerr
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2020, 62 (02) : 259 - 259
  • [4] Commentary: Measuring the success of blinding in RCTs: don't, must, can't or needn't?
    Sackett, David L.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2007, 36 (03) : 664 - 665